Chief Operating Officer & Founder
Dr. Jobes brings over 20 years of research and business development expertise in vaccines, virology and HIV. Dr. Jobes received his Ph.D. in cell and molecular biology from Tulane University. After completing his postdoctoral training at the NIH, Dr. Jobes worked at Applied Biosystems, where he was integrally involved in bringing a novel HIV drug resistance kit to market, ViroSeq®. He then moved to VaxGen where he ran a research group that characterized the HIV strains isolated from VaxGen’s two international Phase 3 HIV vaccine trials. This work has resulted in numerous publications studying the effects of the vaccines in MSMs and IV drug users. Prior to founding Prosper Animal Health, David was a co-founder of Presidio Pharmaceuticals, a small molecule HIV and HCV therapeutic company, whose lead compound is now in Phase 2 clinical trials.
